353235-94-6

Basic information

• Product Name: N-(t-butoxycarbonyl)-N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine
• Synonyms: N-(t-butoxycarbonyl)-N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine
• CAS NO: 353235-94-6
• Molecular Weight: 425.288
• Mol File: 353235-94-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: N-(t-butoxycarbonyl)-N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(t-butoxycarbonyl)-N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine(353235-94-6)
• EPA Substance Registry System: N-(t-butoxycarbonyl)-N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine(353235-94-6)

Safety Data

• Hazardous Substances Data: 353235-94-6(Hazardous Substances Data)

Upstream product

• 353235-93-5 N-(2-(4-iodophenyl)ethyl)-N-(methylsulfonyl)amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 64-04-0 phenethylamine 
• 33893-36-6 N-(methylsulfonyl)(2-phenylethyl)amine 

Downstream Products

• 375346-00-2 [4-[2-[(methylsulfonyl)amino]ethyl]phenyl]boronic acid 
• 375345-95-2 {(2R)-2-[4-(4-{2-[(methylsulfonyl)amino]ethyl}phenyl)phenyl]-propyl}[(methylethyl)sulfonyl]amine 
• 516491-32-0 N,N'-([1,1'-biphenyl]-4,4'-diyldi-2,1-ethanediyl)-bis-methanesulfonamide 
• 375345-99-6 N-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-phenyl]ethyl]methanesulfonamide 
• 344462-93-7 N-carbamic acid tert-butyl ester-N-methanesulfonamide-N-phenethyl-4-boronic acid 
• 353235-95-7 N-(t-butoxycarbonyl)-N-(methylsulfonyl)-N-(2-(4-(4,4,5,5-tetramethyl(1,3,2-dioxaborolan-2-yl))phenyl)ethyl)amine 

Relevant articles and documents

Cyclopentyl sulfonamide derivatives

The present invention provides compounds of formula (I): useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Combination therapy for treatment of depression

The present invention provides a method for treating depression, comprising administering to a patient an effective amount of a first component which is a suitable antidepressant, in combination with an effective amount of a second component which is a suitable AMPA receptor potentiator.

Process for preparing biphenyl compounds

The present invention relates to a process for the preparation of a biphenyl compound comprising combining a phenyl boronic acid derivative with an halobenzene derivative in the presence of a suitable additive in a suitable organic solvent with a suitable catalyst and a suitable base.